Suprateeka Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 15-12-2024
- Paid Up Capital ₹ 1.30 Cr
as on 15-12-2024
- Company Age 10 Year, 12 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 9.60 M
as on 15-12-2024
About Suprateeka Laboratories
The Corporate was formerly known as Helios Bio Nutrition Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.30 Cr.
The company has closed loans amounting to ₹9.60 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ramulu Gajjela and Chelamalla Radhika serve as directors at the Company.
- CIN/LLPIN
U15400TG2014PTC096893
- Company No.
096893
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Suprateeka Laboratories Private Limited offer?
Suprateeka Laboratories Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Ayurvedic & Herbal Health Supplement, Herbal Sexual Health Supplement, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Dietary Supplements, Whey Protein, Vitamin Tablets & Capsules, Ayurvedic Medicine.
Who are the key members and board of directors at Suprateeka Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramulu Gajjela  | Director | 03-Oct-2020 | Current |
| Chelamalla Radhika | Director | 01-Sep-2020 | Current |
Financial Performance of Suprateeka Laboratories.
Suprateeka Laboratories Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Suprateeka Laboratories?
In 2017, Suprateeka Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Doctor Blue Bio Tech (India) Private LimitedActive 13 years 8 monthsRamulu Gajjela and Chelamalla Radhika are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 19 Mar 2015 | ₹9.60 M | Satisfied |
How Many Employees Work at Suprateeka Laboratories?
Unlock and access historical data on people associated with Suprateeka Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suprateeka Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suprateeka Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
